This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
September 2026 consolidated quarter: revenue up 18.9% year on year, net loss widened
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated results for the quarter ended September 30, 2026 versus the year-earlier quarter showed operating revenue of Rs 10,544.56 lakh versus Rs 8,871.13 lakh, up 18.9%, but net loss widened to Rs 204.93 lakh from Rs 42.46 lakh. EBITDA margin fell to about 5.1% from 6.5%. For the consolidated half year, net loss was Rs 606.63 lakh and operating cash flow was positive at Rs 126.93 lakh.
Higher sales did not prevent a wider loss or weaker margins, which may weigh on the stock, though positive half-year cash flow offers support.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹105.4 Cr | ₹88.71 Cr | +18.9% |
| Operating profit | −₹5.04 Cr | −₹2.39 Cr | loss widened |
| Profit after tax | −₹2.05 Cr | −₹0.42 Cr | loss widened |
| EBITDA margin | 5.2% | 6.5% | −1.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.